Skip to content
Screener

Inovio Pharmaceuticals INO Q1 2026 earnings

Reported May 13, 2026 · After market close

EPS-$0.28Beat by $0.02
Revenue estimate$333.3K
EPS estimate-$0.30

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$2.3M
EPS estimate-$0.20

FAQ

When did Inovio Pharmaceuticals report Q1 2026 earnings?
Inovio Pharmaceuticals (INO) reported Q1 2026 earnings on May 13, 2026 after market close.
What were Inovio Pharmaceuticals's Q1 2026 revenue and EPS?
Inovio Pharmaceuticals reported eps of $-0.28 for Q1 2026.
Did Inovio Pharmaceuticals beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.30 by $0.02.
How did Inovio Pharmaceuticals's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 45.1% from $-0.51.
Where can I find Inovio Pharmaceuticals's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001055726-26-000019) and the 10-Q periodic report (0001055726-26-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.